SmartZyme BioPharma Inc.

Industry

  • In Vitro Diagnostics
    • Glucose Testing
  • Medical Devices
    • Monitoring Equipment & Devices
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
See more in Biomedtracker

Latest on SmartZyme BioPharma Inc.

Scrip

Start-Up Quarterly Statistics: Relay, Cerevel Financings Lead Q4 VC Deals

 
• By Deanna Kamienski

Fourth quarter financings for biopharmaceutical start-ups totaled $2.73bn, including Relay Therapeutics 's $400m Series C venture capital round and Cerevel Therapeutics LLC 's $350m Series A round.

Scrip

Deal Watch: Sanofi Retains Options To Two Bispecifics While Exiting Antibody Pact With Regeneron

 
• By Joseph Haas and Emily Hayes

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Sanofi, Regeneron Unwind Lon

Scrip

Deal Watch: Boehringer Teams Up In CNS Disorders Again, This Time With Domain

 
• By Joseph Haas, Alex Shimmings, John Davis, Jessica Merrill, Jo Shorthouse, and Eleanor Malone

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Boehringer Ingelheim Taps In

Scrip

Venture Funding Deals, December 2015

 
• By Deanna Kamienski, Beth Allan, Amanda Micklus, Steven Muntner, and Maureen Riordan

IN VITRO DIAGNOSTICS Biological Dynamics Inc. Biological Dynamics closes $26.8mm Series C round Molecular diagnostics firm Biological Dynamics Inc. raised $26.8mm through its Series C round (o